Healthcare platform

500% increase in users with a new, scalable application.

DjangoHealthcarePlatformAPI

We helped Novo Nordisk replace varied local systems with a scalable clinical trial recruitment platform, making it easier for administrators to manage participant data, export reports and support growth across trials.

Client:
Novo Nordisk
Duration:
Long-term healthcare platform engagement
500% increase in potential trial participants recorded
30,000 potential participants recorded by 2024
API token-authenticated integration for data ownership
Global admin workflows across trials, sites and roles

The challenge

Novo Nordisk needed a way to collect and manage clinical trial recruitment data for its growing number of clinical trials. Previous systems were varied and localised, creating overhead and frustration when teams needed to manage and interpret data across trials.

  • Clinical trial recruitment platform for a growing global trial programme
  • Potential participant records grew from 5,000 in 2020 to nearly 30,000 in 2024
  • Role-based permissions keep sensitive data visible only to the right users
  • A secure token-authenticated API gives Novo Nordisk more ownership over trial, site and user data

Our approach

Together with Novo Nordisk, we analysed evidence from trial recruiters working in clinical settings with limited time, then designed the platform around fast, intuitive workflows. Administrators can add patients to trials with minimal clicks, while role-based permissions make sure users only see information appropriate to their responsibilities.

Security and ownership

We made the application responsive for tablets, laptops and desktop use, and exposed a secure external API so Novo Nordisk could manage users, trials and sites directly. Token authentication gives their teams flexibility and ownership while preserving appropriate data controls.

The results

The new platform makes clinical trial recruitment management smoother and more efficient. Novo Nordisk grew from 5,000 potential trial participants recorded on the platform in 2020 to nearly 30,000 in 2024, with reporting and exports tailored to specific trials, sites and users.